FTS241220P22500
- 0.00
- 0.000.00%
Fortis Newsroom
Jefferies Adjusts Fortis Healthcare's Price Target to INR725 From INR575, Keeps at Buy
National Bank Maintains Fortis(FTS.US) With Hold Rating, Raises Target Price to $45.08
Fortis Maintained at Sector Perform at National Bank Following Q3 Results; Price Target Raised to C$63.00
CIBC Maintains Fortis(FTS.US) With Hold Rating, Cuts Target Price to $45.08
Fortis Analyst Ratings
Wells Fargo Maintains Fortis(FTS.US) With Hold Rating, Cuts Target Price to $45.08
Wells Fargo Maintains Fortis(FTS.US) With Hold Rating, Raises Target Price to $45.38
RBC Capital Maintains Fortis(FTS.US) With Hold Rating, Maintains Target Price $46.82
Wells Fargo Reaffirms Their Hold Rating on Fortis (FTS)
Fortis's Sell Rating: Regulatory Challenges and Below-Average EPS Growth Overshadow Positive Q3'24 Earnings
Raymond James Downgrades Fortis(FTS.US) to Hold Rating, Raises Target Price to $43.94
Fortis Maintained at Sector Perform at National Bank Financial Following Q3 Results; Price Target Kept at C$62.00
RBC Capital Maintains Fortis(FTS.US) With Hold Rating, Raises Target Price to $46.79
J.P. Morgan Maintains Fortis(FTS.US) With Sell Rating, Raises Target Price to $43.44
Fortis Analyst Ratings
CIBC Maintains Fortis(FTS.US) With Hold Rating, Raises Target Price to $45.57
RBC Capital Maintains Fortis(FTS.US) With Hold Rating, Raises Target Price to $47.96
Fortis Inc. Price Target Raised to C$65.00/Share From C$62.00 by RBC Capital
Fortis Inc. Is Maintained at Sector Perform by RBC Capital
RBC Capital Maintains Fortis(FTS.US) With Hold Rating, Maintains Target Price $45.88